ResMed ROE 2006-2019 | RMD

Current and historical return on equity (ROE) values for ResMed (RMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. ResMed ROE for the three months ending March 31, 2019 was 26.46%.
ResMed ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $0.45B $2.02B 22.48%
2018-12-31 $0.45B $1.96B 22.60%
2018-09-30 $0.34B $1.90B 16.70%
2018-06-30 $0.32B $2.06B 15.42%
2018-03-31 $0.31B $2.07B 15.22%
2017-12-31 $0.29B $2.02B 14.51%
2017-09-30 $0.35B $2.05B 18.64%
2017-06-30 $0.34B $1.96B 18.80%
2017-03-31 $0.32B $1.86B 18.43%
2016-12-31 $0.33B $1.71B 19.09%
2016-09-30 $0.35B $1.77B 20.77%
2016-06-30 $0.35B $1.70B 22.23%
2016-03-31 $0.36B $1.67B 22.87%
2015-12-31 $0.36B $1.52B 23.38%
2015-09-30 $0.35B $1.46B 22.81%
2015-06-30 $0.35B $1.59B 22.12%
2015-03-31 $0.35B $1.54B 21.61%
2014-12-31 $0.35B $1.59B 21.05%
2014-09-30 $0.35B $1.65B 20.65%
2014-06-30 $0.35B $1.76B 20.41%
2014-03-31 $0.33B $1.69B 19.96%
2013-12-31 $0.33B $1.64B 19.43%
2013-09-30 $0.32B $1.69B 18.58%
2013-06-30 $0.31B $1.61B 17.98%
2013-03-31 $0.31B $1.77B 18.22%
2012-12-31 $0.29B $1.75B 17.46%
2012-09-30 $0.28B $1.70B 17.04%
2012-06-30 $0.26B $1.61B 16.18%
2012-03-31 $0.24B $1.61B 14.70%
2011-12-31 $0.23B $1.56B 13.84%
2011-09-30 $0.22B $1.55B 13.43%
2011-06-30 $0.23B $1.73B 13.95%
2011-03-31 $0.22B $1.66B 14.64%
2010-12-31 $0.22B $1.61B 15.21%
2010-09-30 $0.21B $1.48B 15.31%
2010-06-30 $0.19B $1.29B 14.96%
2010-03-31 $0.18B $1.33B 14.83%
2009-12-31 $0.17B $1.26B 15.13%
2009-09-30 $0.16B $1.20B 15.04%
2009-06-30 $0.15B $1.12B 14.51%
2009-03-31 $0.13B $0.97B 13.13%
2008-12-31 $0.12B $0.96B 11.93%
2008-09-30 $0.12B $0.97B 11.11%
2008-06-30 $0.11B $1.08B 10.70%
2008-03-31 $0.11B $1.07B 10.91%
2007-12-31 $0.06B $1.02B 6.74%
2007-09-30 $0.07B $0.98B 7.26%
2007-06-30 $0.07B $0.93B 7.82%
2007-03-31 $0.06B $0.87B 7.67%
2006-12-31 $0.10B $0.85B 13.58%
2006-09-30 $0.10B $0.77B 14.18%
2006-06-30 $0.09B $0.74B 14.25%
2006-03-31 $0.08B $0.67B 14.69%
2005-12-31 $0.07B $0.53B 14.63%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.890B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.825B 29.16
Medtronic (MDT) Ireland $135.913B 19.41
Stryker (SYK) United States $78.520B 28.02
Boston Scientific (BSX) United States $59.297B 28.43
Baxter (BAX) United States $42.385B 26.71
EssilorLuxottica Societe Anonyme (ESLOY) France $29.267B 0.00
Coloplast (CLPBY) Denmark $25.937B 41.41
Zimmer Biomet Holdings (ZBH) United States $25.411B 16.33
Lonza Group Ag (LZAGY) Switzerland $25.385B 0.00
Terumo (TRUMY) Japan $21.889B 25.17
Smith & Nephew SNATS (SNN) United Kingdom $19.108B 0.00
Canopy Growth (CGC) Canada $12.379B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.239B 48.98
Insulet (PODD) United States $7.299B 531.83
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Hill-Rom Holdings (HRC) United States $7.083B 21.47
Aurora Cannabis (ACB) Canada $7.048B 69.50
Perrigo (PRGO) Ireland $6.991B 11.82
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.299B 51.41
ICU Medical (ICUI) United States $5.103B 30.45
GW Pharmaceuticals (GWPH) United Kingdom $5.007B 0.00
Neogen (NEOG) United States $3.388B 55.09
NuVasive (NUVA) United States $3.018B 24.64
Agios Pharmaceuticals (AGIO) United States $2.894B 0.00
Hutchison China MediTech (HCM) China $2.829B 0.00
National Vision Holdings (EYE) United States $2.507B 53.42
Quidel (QDEL) United States $2.307B 23.94
Aphria (APHA) $1.619B 0.00
Cardiovascular Systems (CSII) United States $1.549B 889.60
Phibro Animal Health (PAHC) United States $1.229B 18.42
AtriCure (ATRC) United States $1.216B 0.00
VAREX IMAGING (VREX) United States $1.171B 24.86
NanoString Technologies (NSTG) United States $1.107B 0.00
Lantheus Holdings (LNTH) United States $1.086B 28.83
PetIQ (PETQ) United States $1.002B 24.33
Quanterix (QTRX) United States $0.820B 0.00
Cerus (CERS) United States $0.773B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.761B 21.35
Omeros (OMER) United States $0.760B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
TG Therapeutics (TGTX) United States $0.701B 0.00
LeMaitre Vascular (LMAT) United States $0.608B 29.43
Surmodics (SRDX) United States $0.538B 78.24
OraSure Technologies (OSUR) United States $0.525B 24.17
Meridian Bioscience (VIVO) United States $0.492B 15.03
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.465B 0.00
Vapotherm (VAPO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.324B 22.45
BioLife Solutions (BLFS) United States $0.319B 99.82
Cytosorbents (CTSO) United States $0.246B 0.00
Zynex (ZYXI) United States $0.239B 24.60
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.186B 0.00
United Health Products (UEEC) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.167B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.139B 7.32
Female Health (VERU) United States $0.138B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.25
MRI INTERVENTNS (MRIC) United States $0.052B 0.00